Background Precise estimates of mortality in Staphylococcus aureus bacteraemia (SAB) are
important to convey prognosis and guide the design of interventional studies. Objectives We …

Methicillin-resistant Staphylococcus aureus (MRSA) infection is still a major global
healthcare problem. Of concern is S. aureus bacteremia, which exhibits high rates of …

Background Ceftobiprole is a cephalosporin that may be effective for treating complicated
Staphylococcus aureus bacteremia, including methicillin-resistant S. aureus. Methods In this …

Staphylococcus aureus is a major human pathogen that causes a wide range of clinical
infections. It is a leading cause of bacteremia and infective endocarditis as well as …

Invasive Staphylococcus aureus infections are a leading cause of morbidity and mortality in
both hospital and community settings, especially with the widespread emergence of virulent …

Staphylococcus aureus, a Gram-positive bacterium colonizing nares, skin, and the
gastrointestinal tract, frequently invades the skin, soft tissues, and bloodstreams of humans …

Staphylococcus aureus, although generally identified as a commensal, is also a common
cause of human bacterial infections, including of the skin and other soft tissues, bones …

Background. We assessed the impact of infectious disease (ID) consultation on
management and outcome in patients with Staphylococcus aureus bacteremia (SAB) …

Objective Mortality and morbidity of Staphylococcus aureus bacteremia (SAB) still remains
considerably high. We aimed to evaluate the impact of infectious disease consultation (IDC) …

Background Staphylococcus aureus bacteraemia is a common cause of severe community-
acquired and hospital-acquired infection worldwide. We tested the hypothesis that …